questionText: To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the geographic disparities in the prescription of semiglutides for patients with polycystic ovary syndrome.
answerText: While semaglutide is not licensed as a treatment option for polycystic ovary syndrome (PCOS), clinicians can prescribe medicines outside their licensed indication, known as off-label prescribing, where they consider it to be the best treatment option for ...
heading: Polycystic Ovary Syndrome: Semaglutide